NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.

Which of the following is NOT a warning for Kineret?

Malignancies
Serious infections
HBV reactivation
Cardiac failure

The correct answer is: HBV reactivation

Kineret is an interleukin-1 receptor antagonist used to treat rheumatoid arthritis. One of the warnings associated with Kineret is the risk of reactivation of hepatitis B virus (HBV) in patients who are carriers. This reactivation can lead to serious liver problems. Therefore, option C, HBV reactivation, is NOT a warning for Kineret. Options A, B, and D are warnings associated with Kineret. Malignancies, serious infections, and cardiac failure are all potential risks or warnings that should be considered when prescribing or using Kineret.